Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3448-3450.e3. doi: 10.1016/j.cgh.2023.01.014. Epub 2023 Jan 31.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholangitis, Sclerosing* / complications
  • Cholangitis, Sclerosing* / drug therapy
  • Colitis*
  • Colitis, Ulcerative*
  • Humans
  • Retrospective Studies

Substances

  • tofacitinib